Healio (5/6, Young) reports, “A literature review revealed that clinicians more often assigned psychotic and childhood disorder diagnoses to Black vs. white patients, according to a poster presented at the American Psychiatric Association annual meeting.” Investigators “found that clinicians more often assigned psychotic and childhood disorder diagnoses to Black patients vs. white patients, and that white patients were more likely diagnosed with adjustment disorder or ADHD.” The “researchers wrote that ‘unconscious bias and underlying societal structures’ may lead to Black patients receiving more severe diagnoses than their white counterparts.”

Related Links:

— “More research needed on racial bias in diagnosing oppositional defiant disorder,”Kate Young, Healio, May 6, 2024

CNN (5/6, Rogers ) reports, “A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists” published in JAMA Network Open. Among “more than 92,000 adults observed over 28 years, consuming at least 7 grams – a bit over half a tablespoon – of olive oil daily was linked with a 28% lower risk of dementia-related death, compared with those who never or rarely ate olive oil, found the study published Monday.”

MedPage Today (5/6, George ) says, “The relationship remained significant after adjusting for diet quality, including adherence to a Mediterranean diet, and after accounting for APOE4 gene status, the researchers reported.” Additionally, “replacing 5 g (about 1 teaspoon) of margarine and mayonnaise with the equivalent amount of olive oil daily was associated with an 8-14% lower risk of dementia mortality, they noted. Substitutions for other vegetable oils or butter were not significant.”

Related Links:

— MedPage Today (requires login and subscription)

The New York Times (5/4, Baumgaertner ) reported, “Thanks to advancements in medicine and insurance, mortality rates for children in the United States had been shrinking for decades. But last year, researchers uncovered a worrisome reversal: The child death rate was rising.” Now, “a new study, published Saturday in The Journal of the American Medical Association, revealed growing disparities in child death rates across racial and ethnic groups.” Specifically, “Black and Native American youths ages 1 to 19 died at significantly higher rates than white youths – predominantly from injuries such as car accidents, homicides and suicides.”

Related Links:

— “The New York Times (requires login and subscription)

CNN (5/4, McPhillips ) reported, “Deaths from drug overdoses and firearm-related injuries have reached record levels in the United States in recent years, and it’s created a ‘double burden’ for children who face an increased risk of losing their parents and of dying themselves, according to the authors of a new study” published in JAMA. Over “1 million children have lost a parent to a fatal drug overdose or gun violence over the past two decades, according to the study, published Saturday…and the burden has increased significantly over time.” Almost “100,000 children lost parents to a drug overdose or gun violence in 2020 alone – almost three times more than in 1999, the study found. These two causes of death accounted for 23% of all parental loss in 2020, nearly double the share from 1999.”

Related Links:

— “Nearly 100,000 children in the US lost a parent to a drug overdose or gun violence in 2020, study finds,”Deidre McPhillips, CNN, May 4, 2024

Psychiatric News (5/3) reports, “There is still not enough evidence to support the use of pharmacogenetic tests in the treatment of depression, according to updated recommendations from APA’s Workgroup on Biomarkers and Novel Treatments.” For the recommendations published in AJP in Advance, “the workgroup examined data from 11 pharmacogenetic clinical trials conducted between 2017 and 2022, as well as six meta-analyses that combined individual results.” Workgroup members wrote in the updated recommendations, “Despite expert opinions, warnings, and policy statements regarding their limitations for predicting antidepressant treatment response, the popularity of [pharmacogenetic] testing products has grown, with at least 35 U.S. commercial entities providing them by 2020.”

Related Links:

— “Evidence Base for Pharmacogenetic Tests Still Lacking, APA Workgroup Finds, Psychiatric News, May 3, 2024